| Dr Vermon Craig Barney, DDS | |
|
211 North Main, Boulder, MT 59632 | |
| (406) 558-5123 | |
| (406) 225-3150 |
| Full Name | Dr Vermon Craig Barney |
|---|---|
| Gender | Male |
| Speciality | Dentist - Periodontics |
| Location | 211 North Main, Boulder, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891830931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0300X | Dentist - Periodontics | 1852 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vermon Craig Barney, DDS 211 North Main, Po Box 1366, Boulder, MT 59632 Ph: (406) 558-4123 | Dr Vermon Craig Barney, DDS 211 North Main, Boulder, MT 59632 Ph: (406) 558-5123 |
News Archive
Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended December 26, 2009.
Indiana University School of Medicine scientists have successfully transplanted primary kidney cells intravenously to treat renal failure in rats, pointing the way to a possible future alternative to kidney transplants and expensive dialysis treatments in humans.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.
A dual-headed dedicated gamma camera used during molecular breast imaging (MBI) can accurately detect small breast tumors less than 2 cm in size, according to a study performed at the Mayo Clinic in Rochester, MN.
› Verified 3 days ago
Charissa Michelle Martin, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 211 North Main Street, Boulder, MT 59631 Phone: 406-225-4222 Fax: 406-225-4222 |